These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 7676627
1. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site. Wolf J, Jox A, Skarbek H, Pukrop T, Bartnitzke S, Pawlita M, Diehl V, Bullerdiek J. Virology; 1995 Sep 10; 212(1):179-85. PubMed ID: 7676627 [Abstract] [Full Text] [Related]
2. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss. Jox A, Taquia E, Vockerodt M, Draube A, Pawlita M, Möller P, Bullerdiek J, Diehl V, Wolf J. Cancer Res; 1998 Nov 01; 58(21):4930-9. PubMed ID: 9810002 [Abstract] [Full Text] [Related]
3. A Burkitt lymphoma cell line with integrated Epstein-Barr virus at a stable chromosome modification site. Popescu NC, Chen MC, Simpson S, Solinas S, DiPaolo JA. Virology; 1993 Jul 01; 195(1):248-51. PubMed ID: 8391183 [Abstract] [Full Text] [Related]
4. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells. Wolf J, Pawlita M, Klevenz B, Frech B, Freese UK, Müller-Lantzsch N, Diehl V, zur Hausen H. Int J Cancer; 1993 Feb 20; 53(4):621-7. PubMed ID: 8382194 [Abstract] [Full Text] [Related]
5. Integration of Epstein-Barr virus in Burkitt's lymphoma cells leads to a region of enhanced chromosome instability. Jox A, Rohen C, Belge G, Bartnitzke S, Pawlita M, Diehl V, Bullerdiek J, Wolf J. Ann Oncol; 1997 Feb 20; 8 Suppl 2():131-5. PubMed ID: 9209656 [Abstract] [Full Text] [Related]
6. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression. Wolf J, Pawlita M, Bullerdiek J, zur Hausen H. Cancer Res; 1990 May 15; 50(10):3095-100. PubMed ID: 2159373 [Abstract] [Full Text] [Related]
7. Integration of Epstein Barr virus near the breakpoint of a translocation 11;19 in a Burkitt's lymphoma cell line. Wolf J, Pawlita M, Jox A, Kohls S, Bartnitzke S, Diehl V, Bullerdiek J. Cancer Genet Cytogenet; 1993 Jun 15; 67(2):90-4. PubMed ID: 8392436 [Abstract] [Full Text] [Related]
8. Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt's lymphoma cell line (Raji). Gao J, Luo X, Tang K, Li X, Li G. J Virol Methods; 2006 Sep 15; 136(1-2):193-9. PubMed ID: 16806502 [Abstract] [Full Text] [Related]
9. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines. Steel CM, Morten JE, Foster E. IARC Sci Publ; 1985 Sep 15; (60):265-92. PubMed ID: 2998993 [Abstract] [Full Text] [Related]
10. Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs Burkitt's lymphoma cell lines. Jiang R, Kanamori M, Satoh Y, Fukuda M, Ikuta K, Murakami M, Sairenji T. J Med Virol; 2003 Jun 15; 70(2):244-52. PubMed ID: 12696111 [Abstract] [Full Text] [Related]
11. An origin of DNA replication (oriP) in highly methylated episomal Epstein-Barr virus DNA localizes to a 4.5-kb unmethylated region. Falk K, Ernberg I. Virology; 1993 Aug 15; 195(2):608-15. PubMed ID: 8393238 [Abstract] [Full Text] [Related]
12. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines. Sinclair AJ, Jacquemin MG, Brooks L, Shanahan F, Brimmell M, Rowe M, Farrell PJ. Virology; 1994 Mar 15; 199(2):339-53. PubMed ID: 8122366 [Abstract] [Full Text] [Related]
13. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells. Hu LF, Chen F, Altiok E, Winberg G, Klein G, Ernberg I. Gan To Kagaku Ryoho; 2000 May 15; 27 Suppl 2():248-60. PubMed ID: 10895161 [Abstract] [Full Text] [Related]
14. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines. Röth A, Pfaff P, Lange W, Finke J. Cytokines Mol Ther; 1996 Mar 15; 2(1):21-8. PubMed ID: 9384686 [Abstract] [Full Text] [Related]
15. De novo DNA methylation at nonrandom founder sites 5' from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes. Salamon D, Takacs M, Myöhänen S, Marcsek Z, Berencsi G, Minarovits J. Biol Chem; 2000 Feb 15; 381(2):95-105. PubMed ID: 10746740 [Abstract] [Full Text] [Related]
16. Examination of Epstein-Barr virus and C-type proviral sequences in American and African lymphomas and derivative cell lines. Pizzo PA, Chattopadhyay SK, Magrath IT, Del Giacco E, Sherrick D, Gray T. Cancer Res; 1981 Aug 15; 41(8):3165-71. PubMed ID: 6265077 [Abstract] [Full Text] [Related]
17. Reversion of tumorigenicity in an EBV-converted Burkitt's lymphoma line. Klein G. Ciba Found Symp; 1989 Aug 15; 142():36-48; discussion 48-53. PubMed ID: 2545422 [Abstract] [Full Text] [Related]
18. Visualization of episomal and integrated Epstein-Barr virus DNA by fiber fluorescence in situ hybridization. Reisinger J, Rumpler S, Lion T, Ambros PF. Int J Cancer; 2006 Apr 01; 118(7):1603-8. PubMed ID: 16217752 [Abstract] [Full Text] [Related]
19. Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines. Mochida A, Gotoh E, Senpuku H, Harada S, Kitamura R, Takahashi T, Yanagi K. Arch Virol; 2005 Oct 01; 150(10):2139-50. PubMed ID: 15986178 [Abstract] [Full Text] [Related]
20. Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review. Tatsumi E. Hum Cell; 1992 Mar 01; 5(1):79-86. PubMed ID: 1329932 [Abstract] [Full Text] [Related] Page: [Next] [New Search]